Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,321 | -8,806 | -9,470 | -7,508 | -28,491 |
| Depreciation Amortization | 325 | 352 | 424 | 554 | 1,563 |
| Accounts receivable | -7,636 | 454 | 9 | -670 | 633 |
| Accounts payable and accrued liabilities | 2,861 | -258 | 440 | -179 | -2,573 |
| Other Working Capital | -4,774 | -61 | 255 | -848 | -2,001 |
| Other Operating Activity | 877 | -173 | -376 | 389 | 18,926 |
| Operating Cash Flow | $-15,668 | $-8,491 | $-8,718 | $-8,262 | $-11,943 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -27 | -52 | -382 | -85 |
| Purchase Sale Intangibles | -978 | -295 | N/A | N/A | N/A |
| Other Investing Activity | -753 | -302 | -220 | 0 | 3,390 |
| Investing Cash Flow | $-764 | $-330 | $-272 | $-382 | $3,305 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 551 | N/A | N/A | N/A | 58 |
| Debt Issued | N/A | N/A | N/A | -142 | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -294 |
| Common Stock Issued | 10,622 | 12,970 | 301 | 12,424 | 12,509 |
| Other Financing Activity | -238 | -250 | -243 | -175 | -8,313 |
| Financing Cash Flow | $10,935 | $12,720 | $58 | $12,108 | $3,960 |
| Exchange Rate Effect | N/A | N/A | N/A | -11 | 335 |
| Beginning Cash Position | 7,630 | 3,528 | 12,440 | 10,377 | 14,032 |
| End Cash Position | 2,133 | 7,427 | 3,508 | 13,829 | 9,689 |
| Net Cash Flow | $-5,498 | $3,900 | $-8,932 | $3,453 | $-4,343 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,668 | -8,491 | -8,718 | -8,262 | -11,943 |
| Capital Expenditure | -12 | -32 | -77 | -440 | -268 |
| Free Cash Flow | -15,680 | -8,523 | -8,794 | -8,702 | -12,211 |